Policies & RegulationsPharmacyHospitalsPharma & DistributionDrug ApprovalsIP IssuesDomestic NDD
  news bulletin  
SK Chemicals appointed new President and VP
by Eui Kyoung Yoon (ekyeun@dreamdrug.com)
Published : Dec 11, 2014 03:45:19
SK Chemicals said on December 9 that it decided to promote Park Mahn Hoon, Director of Life Science Laboratory, to President and Chief Technology Officer.

Park started working for SK Chemicals in 2008 and has led vaccine business and research and development. Recently he helped Sanofi Pasteur agree with co-development and commercialization of the next generation pneumonia vaccine.

SK also decided to promote Han Byung Ro, Head of Management Support Department to Vice President. Han worked through the departments of finance, business development, human resources, and various fields, stabilizing the relationship with its labor union.

Park and Han’s promotions are effective on January 1, 2015. Lee In Suk, current President, will take the position of one of business advisors after his retirement.
 
Reply 0
Name Password
Text
 
Popular News
 
Champix to be covered, starting Feb 2015
First generic version of Omacor approved
OTC drugs will be available at some resorts
Novartis Korea and KPWA agreed on margin increase
MSD’s new COX-2 inhibitor Arcoxia approved
All materials contained on this site are protected by Korean copyright law and may not be reproduced, distributed, transmitted,
displayed, published or broadcast without the prior consent of dailypharm.com